The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: meropenem     Quarter: 2016Q3

Total Records: 349     Number of Pages: 18

DRUGNAME PT EventCount
MEROPENEM ANHYDROUS Hepatosplenic candidiasis 1
MEROPENEM ANHYDROUS Hypokalaemia 1
MEROPENEM ANHYDROUS Nephrogenic diabetes insipidus 1
MEROPENEM ANHYDROUS Systemic candida 1
MEROPENEM ANHYDROUS Transaminases increased 1
MEROPENEM ANHYDROUS Tumour lysis syndrome 1
MEROPENEM FOR INJECTION USP AND SODIUM CHLORIDE INJECTION USP IN THE Delirium 1
MEROPENEM HIKMA Atrial fibrillation 1
MEROPENEM HIKMA Cardiac failure 1
MEROPENEM HIKMA Chronic kidney disease 1
MEROPENEM HIKMA Clostridium difficile infection 1
MEROPENEM HIKMA Condition aggravated 1
MEROPENEM HIKMA Cough 1
Meropenem Hikma Drug interaction 1
MEROPENEM HIKMA Erysipelas 1
Meropenem Hikma Erythema 1
MEROPENEM HIKMA Fungal oesophagitis 1
MEROPENEM HIKMA Gout 1
MEROPENEM HIKMA Hepatic enzyme increased 1
Meropenem Hikma Myoclonus 1

Total Records: 349     Number of Pages: 18